# A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

Study · id `cardio:ct-nct01539616` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01539616](<https://clinicaltrials.gov/study/NCT01539616>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01539616

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.

## Technical summary

Registry record NCT01539616. Randomized; triple masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 109 participants (enrolled count; ClinicalTrials.gov record NCT01539616, source copy `cardio:ctgov-nct01539616-2013-10-28`, retrieved 2026-10-31)
- Start date: 2011-11 (registry gives no type) (ClinicalTrials.gov record NCT01539616, source copy `cardio:ctgov-nct01539616-2013-10-28`, retrieved 2026-10-31)
- Primary completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01539616, source copy `cardio:ctgov-nct01539616-2013-10-28`, retrieved 2026-10-31)
- Completion: 2012-08 (actual) (ClinicalTrials.gov record NCT01539616, source copy `cardio:ctgov-nct01539616-2013-10-28`, retrieved 2026-10-31)
- Countries: India (ClinicalTrials.gov record NCT01539616, source copy `cardio:ctgov-nct01539616-2013-10-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01539616-2013-10-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia
- Condition: Hypertriglyceridemia
- Condition: Dyslipidemia
- Intervention (Drug): ZYH7
- Intervention (Drug): ZYH7
- Intervention (Drug): ZYH7
- Intervention (Drug): Fenofibrate
- Lead sponsor: Zydus Lifesciences Limited
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High triglycerides (`cardio:hypertriglyceridemia`)
- Registry lists this organization as the lead sponsor: Zydus Lifesciences Limited (`cardio:org-zydus-lifesciences-limited`)

## Provenance

Content hash: 17d33a5b0dd1601e1dcfe729f7b81a0eee46a399415466beedf8cedcf8935182
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
